About Cypher Genomics
Cypher Genomics is a company based in San Diego (United States) founded in 2011 was acquired by Human Longevity in November 2015. It operates as a Professional Services. The company has 83 employees. Cypher Genomics offers products and services including Mantis Genomic Coral Biomarker Array Chip and qPCR Assay. Cypher Genomics operates in a competitive market with competitors including GSK, DNAnexus, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
- Headquarter San Diego, United States
- Employees 83
- SectorsHealthcare
- Website cyphergenomics.com
- Social LinkedIn X
- Acquired by Human Longevity (Nov 2015)
- Legal Name Human Longevity, Inc.
- InvestorsHuman Longevity
& 2 more
- Employee Count83
- Acquired byHuman Longevity
(Nov 2015)
Products & Services of Cypher Genomics
Cypher Genomics offers a comprehensive portfolio of products and services, including Mantis Genomic Coral Biomarker Array Chip and qPCR Assay.
Used for detecting biomarkers in genomic research assays.
Employed for precise quantification of genetic material samples.
Funding Insights of Cypher Genomics
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of Cypher Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2015 | – | Seed | – | – | |
| Jul 2014 | – | Seed | – | EvoNexus | – |
3 investors in total: 3 institutional.
Investors in Cypher Genomics
Cypher Genomics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Human Longevity, Three Leaf Ventures and EvoNexus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage centric sector-agnostic venture capital firm funding companies in the US | – | threeleafventures.com | Denver, United States | |
12-18 month incubation programs are provided for startups in California. | – | evonexus.org | San Diego, United States | |
Genomics data and cell therapy-based diagnostic and therapeutic solutions | 2013 | humanlongevity.com | San Diego, United States |
Investor details for Cypher Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cypher Genomics
14 people are tracked at Cypher Genomics (4 in leadership, 10 in board & advisors); the tracked headcount is 83.
| Name | Role | Group |
|---|---|---|
Adam Simpson | President & Chief Operating Officer | Leadership |
Ali Torkamani | Co-Founder & Chief Scientific Officer | Leadership |
J. Patrick Ravenel | Chief Technology Officer | Leadership |
Ashley Van Zeeland | Co-Founder & CEO | Leadership |
Hank Nordhoff | Executive Chairman | Board & advisors |
Nicholas Schork | Chair, Scientific Advisory Board & Co-Founder | Board & advisors |
Herb Boyer | Director | Board & advisors |
Eric Topol | Director | Board & advisors |
Andy Von Eschenbach | Director | Board & advisors |
Kelly Bethel | Scientific Advisor | Board & advisors |
Michael Hultner | Scientific Advisor | Board & advisors |
Myla Lai-Goldman | Scientific Advisor | Board & advisors |
Arnold Levine | Scientific Advisor | Board & advisors |
Diego Miralles | Scientific Advisor | Board & advisors |
Complete people profiles for Cypher Genomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cypher Genomics
4 dated milestones of Cypher Genomics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Cypher Genomics is founded.
- Funding First funding round.
- Funding Latest funding round, Seed,.
- Exit Acquired by Human Longevity.
Competitors of Cypher Genomics
Cypher Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, DNAnexus, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| dnanexus.com | 2009 | Mountain View, United States | $472.55M | 143 | Cloud-based genome informatics and data management are provided. | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. |
Detailed competitors of Cypher Genomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Cypher Genomics
10 companies that operate in the same segment as Cypher Genomics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cypher Genomics
Cypher Genomics was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Cypher Genomics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Cypher Genomics has 83 employees.
Cypher Genomics is involved in the development of genomic diagnostic tools and assays. The company focuses on solutions like the Mantis Genomic Coral Biomarker Array Chip and qPCR assays, targeting the biotechnology sector. Its offerings are utilized in research for detecting biomarkers, proteins, and molecules associated with various conditions. The company also provides resources and references for lab reagents and antibodies through its platform.
Cypher Genomics's top competitors include DNAnexus, Sutro Biopharma and Synthego.
Cypher Genomics offers Mantis Genomic Coral Biomarker Array Chip and qPCR Assay.
Cypher Genomics has 3 investors. Key investors include Human Longevity, Three Leaf Ventures, and EvoNexus.
Cypher Genomics operates through Human Longevity, Inc..
Yes. Cypher Genomics was acquired by Human Longevity in November 2015.